SWAlexander
Senior Member
- Messages
- 2,097
Reading a story from a cancer patient`s success, I wonder if PDL immunotherapy would work for ME/CFS.
What is PDL immunotherapy?
PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1.
What does PD-L1 stand for?
Programmed Death-Ligand 1 (PD-L1) is a protein that can be found on the surface of many cells throughout the body. Some, but not all, tumor cells have large amounts of PD-L1 that help the tumor cells evade the body's natural defense system—the immune system.
What is the difference between PD-L1 and PD-1?
PD-1 antibodies are IgG4, whereas the PD-L1 antibodies harbor unmodified (avelumab) or modified IgG1 Fc sequences (durvalumab and atezolizumab). In addition to PD-1, PD-L1 also binds CD80, a molecule which has an important role as a costimulatory ligand
https://www.nature.com/articles/s41598-019-47910-1
What type of immunotherapy is Keytruda?
KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells.
https://www.researchgate.net/public..._treatment_ameliorates_airway_hyperreactivity
However, Keytruda (generic drug pembrolizumab) is expensive in the US
Pembrolizumab is available in single-use vials of 100 mg and is administered at a dose of 200 mg every 3 weeks. The list price for pembrolizumab is $US4381 per 100-mg vial, therefore the cost per dose is $US8762
What is PDL immunotherapy?
PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1.
What does PD-L1 stand for?
Programmed Death-Ligand 1 (PD-L1) is a protein that can be found on the surface of many cells throughout the body. Some, but not all, tumor cells have large amounts of PD-L1 that help the tumor cells evade the body's natural defense system—the immune system.
What is the difference between PD-L1 and PD-1?
PD-1 antibodies are IgG4, whereas the PD-L1 antibodies harbor unmodified (avelumab) or modified IgG1 Fc sequences (durvalumab and atezolizumab). In addition to PD-1, PD-L1 also binds CD80, a molecule which has an important role as a costimulatory ligand
https://www.nature.com/articles/s41598-019-47910-1
What type of immunotherapy is Keytruda?
KEYTRUDA is a type of immunotherapy that works by blocking the PD-1 pathway to help prevent cancer cells from hiding. KEYTRUDA helps the immune system do what it was meant to do: detect and fight cancer cells.
https://www.researchgate.net/public..._treatment_ameliorates_airway_hyperreactivity
However, Keytruda (generic drug pembrolizumab) is expensive in the US
Pembrolizumab is available in single-use vials of 100 mg and is administered at a dose of 200 mg every 3 weeks. The list price for pembrolizumab is $US4381 per 100-mg vial, therefore the cost per dose is $US8762
Last edited: